Barinthus Biotherapeutics plc (FRA:2AB)
Germany · Delayed Price · Currency is EUR 0.5550
-0.0250 (-4.31%)
Last updated: May 18, 2026, 8:05 AM CET
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of €23.89 million as of May 18, 2026. Its market cap has decreased by -38.74% in one year.
Market Cap
23.89M
Enterprise Value
-23.24M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.56
Market Cap Chart
Since April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from 399.28M to 23.89M, a decrease of -94.02%. That is a compound annual growth rate of -42.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 23.89M | -1.88% |
| Dec 31, 2025 | 24.35M | -48.13% |
| Dec 31, 2024 | 46.94M | -63.54% |
| Dec 29, 2023 | 128.74M | 56.98% |
| Dec 30, 2022 | 82.01M | -75.93% |
| Dec 31, 2021 | 340.74M | -14.66% |
| Apr 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| edding AG | 35.90M |
| Biomark Diagnostics | 35.73M |
| learnd SE | 31.25M |
| Petro Matad | 27.88M |
| Rubean AG | 25.25M |
| Hyrican Informationssysteme Aktiengesellschaft | 24.25M |
| ACCENTRO Real Estate AG | 22.40M |
| Weng Fine Art AG | 21.86M |